Tendonitis Treatment Market– Statistics And Analysis & Forecast To 2030

Posted by Mrudula Anil Karmarkar on July 26th, 2023

The global tendonitis treatment market size is expected to reach USD 281.8 billion by 2030, registering a CAGR of 3.7% over the forecast period, according to a new report by Grand View Research, Inc. Growing participation in physical and sporting activities, directly influences the rise in prevalence of sports-related injuries. In addition, the rising incidence of occupational injuries is anticipated to contribute to the development and growth of the industry over the forecast period. The growing global geriatric population is susceptible to bone disorders, diabetes, arthritis, osteoarthritis, osteoporosis, or tendonitis. Industry participants that are constantly innovating advanced therapies and technologies in managing tendonitis are also contributing to the market growth.

Growing investments, industry collaborations, and increasing favorable government support are other key factors accelerating market growth. Over the past years, there has been a transition from proactive to preventive therapies in managing the health of sportspersons in preventing injuries. According to Standard Children’s Health, in 2018, approximately 3.5 million out of 30 million adolescents participating in sporting activities in the U.S. incur sports-related injuries. As per studies, annually, around 775,000 adolescents receive therapies and treatments for sports-related injuries in the U.S. Major players are expanding their business footprint in both developed and emerging economies through product innovation and strengthening their distribution cycles.

During the COVID-19 pandemic and enforced lockdowns and travel restrictions imposed across countries, the industry growth was negatively impacted owing to a decline in the number of tendonitis treatment procedures. Postponement and cancellation of sporting events led to a decline in the incidence of sports-related injuries, thereby, resulting in a decline in the business performance of the market. In 2021, the therapy segment accounted for the largest share and is anticipated to grow significantly over the forecast period. This is owing to the high preference for non-invasive treatment procedures. The first line of treatment management is physical therapy, which is expected to witness considerable growth.

The Achilles tendonitis segment dominated the industry in 2021. This growth can be attributed to the growing incidence of sports-related injuries in sports players. As per studies, the incidence rate of Achilles tendonitis ranges between 5 to 10 individuals per 100,000 people. North America accounted for the largest share in 2021 owing to the presence of renowned manufacturers and distributors, growing incidence of sports-related & trauma injuries, and rising awareness about the availability of various therapies & surgical procedures.

A growing aging population and sports & occupational work injuries & sudden injuries caused due to trauma or physical work are some of the factors that cause tendonitis, thereby contributing to the industry growth. Adolescents are becoming susceptible to arm-, wrist-, and hand-related injuries owing to the increasing usage of electronic devices, thereby, making them more prone to developing tendonitis. The growing prevalence of bone disorders, osteoarthritis, rheumatoid arthritis, and osteoporosis makes the geriatric population group susceptible to tendonitis.

To Request Sample Copy of this report, click the link:

https://www.grandviewresearch.com/industry-analysis/tendonitis-treatment-market-report/request/rs1

Annually, over 70,000 U.S. individuals suffering from tendonitis miss their work, as per the Bureau of Labor Statistics. As per the WHO estimates in 2021, approximately 1.71 billion individuals globally are affected by musculoskeletal conditions and are prone to tendonitis. The increasing incidence of sports-related injuries due to the increased sports activities is contributing to the market growth. The adoption of healthy habits is increasing with people across the world taking up at least some physical activity regularly, this is anticipated to increase the incidence of sports injuries thereby contributing to the industry growth. Sports injuries make up 12% of the total injuries that are reported at hospitals in the U.S., most of which are tendon-related injuries.

According to a study published by sports medicine professors from Duke University and the University of Virginia, approximately 40 to 50% of competitive runners have suffered from Achilles tendinopathy. The growing incidence of tendonitis in the general population, which accounts for 5 to 10 cases per 100,000 people is attributed to an increase in the market demand during the forecast period. Various treatment options, such as OTC drugs, surgeries, and physical therapy have increased the number of individuals undergoing treatments, which will encourage the industry's growth. Physical therapy is one of the first lines of treatment for people with chronic tendon conditions as it helps in eccentric strengthening and is effective to treat chronic tendon conditions.

Tendonitis Treatment Market Report Highlights

  • The industry is expected to have significant growth over the forecast period owing to the increasing participation in physical & sporting events, leading to a growth in the number of injuries, thereby requiring therapies and surgeries
  • The emergence of innovative and advanced solutions is responsible for industry growth over the forecast period
  • In 2021, the therapy treatment segment accounted for the largest revenue share owing to the increased preference for non-invasive treatment over the surgical procedure for tendonitis
  • Based on the condition type, Achilles tendonitis held the largest revenue share in 2021 owing to the increased incidence of sports injuries
  • North America was the largest region in 2021 on account of the high number of surgeries performed in the region

According to the international journal of physiotherapy, physical therapy is efficient to treat lower limb and upper limb tendinopathies, and these factors are attributed to an increase in the demand for the market during the forecast period. Tendons are highly aligned connective tissues that help transmit force from muscles to bones, hence these tissues are at a higher risk to get injured; over 32 million tendon-related injuries are reported every year, and tendinopathies are 50% of the injuries reported in sports players, and athletes. Sudden injuries, prolonged inactivity, and treatment-associated side effects are attributed to drive the industry during the forecast period.

Continuous innovations in tendon replacement and regeneration techniques addressing the growing demand for alternative engineered tissue are driving the industry. The tendonitis treatment business globally has been negatively impacted by the COVID-19 pandemic. After the onset of the pandemic, non-essential surgeries were rescheduled due to the sudden increase in the requirement of hospital beds to treat COVID-19-infected patients, thereby hampering the industry's growth. Shortage of personal protective gear and infrastructural restructuring forced healthcare units to prioritize and reschedule surgical procedures. Treatment options, such as physical therapy and surgical procedures, were not considered essential and were therefore rescheduled, which hampered the growth.

Some of the prominent players in the global tendonitis treatment market include:

  • Merck and Co., Inc.
  • Bayer AG
  • AstraZeneca
  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Abbott
  • Pfizer
  • GlaxoSmithKline PLC
  • Almatica Pharma, Inc.
  • Teva Pharmaceuticals Industries

Like it? Share it!


Mrudula Anil Karmarkar

About the Author

Mrudula Anil Karmarkar
Joined: July 2nd, 2020
Articles Posted: 1,956

More by this author